BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Psoriatic Arthritis News and Headlines
Psoriatic Arthritis News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Psoriatic Arthritis news alerts.
Site Map > Biotechnology News > Health News > Psoriatic Arthritis
.

Centocor, Inc. submits application to FDA requesting approval of Golimumab for the treatment of Rheumatoid Art
Checkbiotech:  similar ...
Centocor, Inc. Submits BLA to FDA for Golimumab in the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis
Ein News:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
San Francisco Business Times:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
The Business Journal Phoenix:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
Portland Business Journal:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
San Antonio Business Journal:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
Nashville Business Journal:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
Atlanta Business Chronicle:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
Biz Journals:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
Columbus Business First:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
NewsBlaze:  similar ...
Centocor, Inc. Submits BLA to FDA for Golimumab in the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis
Ein News:  similar ...
Centocor, Inc. Submits BLA to FDA for Golimumab in the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis
Pharma Live:  similar ...
Centocor, Inc. Submits BLA to FDA for Golimumab in the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis
Therapeutics Daily:  similar ...
Adalimumab Effective in Patients With Rheumatic Disease Unresponsive to Other Anti-TNF Therapies
Doctors Guide:  similar ...
Adalimumab Effective in Patients With Rheumatic Disease Unresponsive to Other Anti-TNF Therapies
PSL Group:  similar ...
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients
Healthcare Sales & Marketing Network:  similar ...
COMMUNIQUE: PR Newswire: New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus
Belga Direct Press Releases:  similar ...
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic
FinanzNachrichten.de:  similar ...
Adalimumab Therapy Effective in Ankylosing Spondylitis, Rheumatoid Arthritis and Psoriatic Arthritis Patients
Pharma Live:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.